TERRI ANN SAUNDERS: Open Payments
NPI 1447724711 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,889 in 225 payments from 17 companies in 2025. Trend: 2023 $3,356 · 2024 $3,365 · 2025 $3,889
Food & beverage: $3,889
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 40 | $849 |
| Teva Pharmaceuticals USA, Inc. | 42 | $449 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $352 |
| Janssen Pharmaceuticals, Inc | 16 | $324 |
| Vanda Pharmaceuticals Inc. | 12 | $294 |
| Otsuka America Pharmaceutical, Inc. | 13 | $292 |
| E.R. Squibb & Sons, L.L.C. | 16 | $284 |
| ABBVIE INC. | 30 | $268 |
| Axsome Therapeutics, Inc. | 10 | $247 |
| Alkermes, Inc. | 9 | $202 |
Products named: INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, COBENFY, VRAYLAR, UZEDY, Auvelity.
Industry payments across FL — which companies pay providers there.
